Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The quest to prevent MS — and understand other post-viral diseases

False coloured transmission electron micrograph of Epstein-Barr virus

A small number of people infected with Epstein-Barr virus (pictured) go on to develop multiple sclerosis years later. Credit: Dr Gopal Murti/SPL

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 603, 784-786 (2022)


Updates & Corrections

  • Clarification 07 April 2022: An earlier version of this story stated that Katherine Luzuriaga is the lead investigator on the mRNA-1189 trial. She is, in fact, the lead investigator only for the UMass Chan part of the trial.


  1. Bjornevik, K. et al. Science 375, 296–301 (2022).

    Article  PubMed  Google Scholar 

  2. Lanz, T. V. et al. Nature 603, 321–327 (2022).

    Article  PubMed  Google Scholar 

  3. Cohen, J. I. Clin. Transl. Immunol. 4, e32 (2015).

    Article  Google Scholar 

  4. Luzuriaga, K. & Sullivan, J. L. N. Engl. J. Med. 362, 1993–2000 (2010).

    Article  PubMed  Google Scholar 

  5. Messick, T. E. et al. Sci. Transl. Med. 11, eaau5612 (2019).

    Article  PubMed  Google Scholar 

  6. Lebrun-Frenay, C. et al. Ann. Neurol. 88, 407–417 (2020).

    Article  PubMed  Google Scholar 

  7. Douaud, G. et al. Nature (2022).

    Article  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links